Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Global disparities in faecal microbiota transplantation research.
Olesen SW, Panchal P, Chen J, Budree S, Osman M. Olesen SW, et al. Among authors: budree s. Lancet Gastroenterol Hepatol. 2020 Mar;5(3):241. doi: 10.1016/S2468-1253(19)30452-2. Lancet Gastroenterol Hepatol. 2020. PMID: 32061326 No abstract available.
Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.
Panchal P, Budree S, Scheeler A, Medina G, Seng M, Wong WF, Elliott R, Eliott R, Mitchell T, Kassam Z, Allegretti JR, Osman M. Panchal P, et al. Among authors: budree s. Curr Gastroenterol Rep. 2018 Mar 28;20(4):14. doi: 10.1007/s11894-018-0619-8. Curr Gastroenterol Rep. 2018. PMID: 29594746 Review.
Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose.
Allegretti JR, Fischer M, Sagi SV, Bohm ME, Fadda HM, Ranmal SR, Budree S, Basit AW, Glettig DL, de la Serna EL, Gentile A, Gerardin Y, Timberlake S, Sadovsky R, Smith M, Kassam Z. Allegretti JR, et al. Among authors: budree s. Dig Dis Sci. 2019 Jun;64(6):1672-1678. doi: 10.1007/s10620-018-5396-6. Epub 2018 Dec 5. Dig Dis Sci. 2019. PMID: 30519847
Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose.
Allegretti JR, Fischer M, Sagi SV, Bohm ME, Fadda HM, Ranmal SR, Budree S, Basit AW, Glettig DL, de la Serna EL, Gentile A, Gerardin Y, Timberlake S, Sadovsky R, Smith M, Kassam Z. Allegretti JR, et al. Among authors: budree s. Dig Dis Sci. 2019 Jul;64(7):2059. doi: 10.1007/s10620-019-05527-4. Dig Dis Sci. 2019. PMID: 30778870
Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ. Aroniadis OC, et al. Among authors: budree s. Lancet Gastroenterol Hepatol. 2019 Sep;4(9):675-685. doi: 10.1016/S2468-1253(19)30198-0. Epub 2019 Jul 17. Lancet Gastroenterol Hepatol. 2019. PMID: 31326345 Clinical Trial.
Donor Screening for Fecal Microbiota Transplantation.
Kassam Z, Dubois N, Ramakrishna B, Ling K, Qazi T, Smith M, Kelly CR, Fischer M, Allegretti JR, Budree S, Panchal P, Kelly CP, Osman M. Kassam Z, et al. Among authors: budree s. N Engl J Med. 2019 Nov 21;381(21):2070-2072. doi: 10.1056/NEJMc1913670. Epub 2019 Oct 30. N Engl J Med. 2019. PMID: 31665572 No abstract available.
Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation.
Allegretti JR, Elliott RJ, Ladha A, Njenga M, Warren K, O'Brien K, Budree S, Osman M, Fischer M, Kelly CR, Kassam Z. Allegretti JR, et al. Among authors: budree s. Gut Microbes. 2020 Nov 1;11(6):1806-1808. doi: 10.1080/19490976.2020.1768777. Epub 2020 Jun 18. Gut Microbes. 2020. PMID: 32552337 Free PMC article. No abstract available.
22 results